Antimeningococcal herd immunity in the Czech Republic - Influence of an emerging clone, Neisseria meningitidis ET-15/37

Epidemiology and Infection

Volumn 123, Issue 2, 1999, Pages 193-200

  Kriz, P ^a   Kriz, B ^a   Svandova, E ^a   Musilek, M ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIGENIC VARIATION; ARTICLE; BLOOD GROUP TYPING; CHILD; CLONE; CZECH REPUBLIC; HUMAN; IMMUNITY; INFANT; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NEWBORN; NONHUMAN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; ANTIGENS, BACTERIAL; CARRIER STATE; CHILD; CHILD, PRESCHOOL; CZECH REPUBLIC; HUMANS; IMMUNITY, NATURAL; INFANT; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; NEISSERIA MENINGITIDIS; PHENOTYPE; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES;

EID: 0032750396     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S095026889900285X     Document Type: Article

References (15)

1. Kuzemenska P, Kriz B. Epidemiology of meningococcal disease in Central and Eastern Europe. In: Vedros NA, ed. Evolution of meningococcal disease. Vol I. Boca Raton, Florida: CRC Press, Inc, 1987: 103-37.
2. Krizova P, Musilek M. Changing epidemiology of meningococcal invasive disease in the Czech Republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37. Cent Eur J Public Health 1995; 3: 189-94.
3. Krizova P, Musilek M, Kalmusova J. Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37. Cent Eur J Public Health 1997; 5: 214-8.
4. Kuzemenska P, Kriz B. Immunological survey of meningococcal antibodies in healthy population of Czech Republic. In: 5th European Congress of Clinical Microbiology and Infectious Diseases, Oslo 1991, abstract 93.
5. Kriz P, Kriz B. Significance of bactericidal antibodies directed against capsular and noncapsular antigens of Neisseria meningitidis. In: Neisseria 94, 9th International Pathogenic Neisseria Conference, Winchester, 1994, Proceedings: 381-2.
6. Multipurpose Serological Surveys and WHO Serum Reference Banks. WHO Technical Report Series 1970; 454: 1-95.
7. Twenty-seventh report of the WHO Expert Committee on Biological Standardization. WHO Technical Report Series 1976; 594: 72-3.
8. Ambrosh F, Stemberger H, Wiedermann G, Stanek G, Jovanovic D. Determination of meningococcal antibodies by microassay. Bull WHO 1977; 56: 787-90.
9. Maslanka SE, Gheesling LL, Libutti DE, et al. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assay. Clin Diagn Lab Immunol 1997; 4: 156-67.
10. Abdillahi H, Poolman JT. Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 1987; 48: 369-71.
11. Selander RK, Caugant DA, Ochman H, Musser JM, Gilmour MN, Whittam TS. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol 1986; 51: 873-84.
12. Burian V, Gotschlich E, Kuzemenska P, Svandova E. Naturally occurring antibodies to Neisseria meningitidis. Bull WHO 1977; 55: 653-7.
13. Reller LB, MacGregor RR, Beaty HN. Bactericidal antibody after colonization with Neisseria meningitidis. J Infect Dis 1973; 127: 56-62.
14. Kriz P, Giorgini D, Musilek M, Larribe M, Taha MK. Microevolution through DNA exchange among strains of Neisseria meningitidis isolated during an epidemic in the Czech Republic. Microbiology. In press.
15. Kriz P, Vlckova J, Bobak M. Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic. Epidemiol Infect 1995; 115: 411-8.